Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Chevallier, Patrice  [Clear All Filters]
2018
Lee, C.J., Labopin, M., Beelen, D., Finke, J., Blaise, D., Ganser, A., Itälä-Remes, M., Chevallier, P., Labussière-Wallet, H., Maertens, J., et al. (2018). Comparative Outcomes of Myeloablative and Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Acute Myeloid Leukemia with Prior Solid Tumor: a report from the ALWP of the EBMT.Am J Hematol.
Robin, M., Porcher, R., Ruggeri, A., Blaise, D., Wolschke, C., Koster, L., Angelucci, E., Stölzel, F., Potter, V., Yakoub-Agha, I., et al. (2018). HLA mismatched donors in patients with myelodysplastic syndrome: an EBMT registry analysis.Biol Blood Marrow Transplant.
Kyriakou, C., Boumendil, A., Finel, H., Finel, H., Andersen, N.Smedegaard, Blaise, D., Chevallier, P., Browne, P., Malladi, R., Niederwieser, D., et al. (2018). The impact of advanced patient age on mortality after allogeneic hematopoietic Cell Transplantation for Non-Hodgkin's Lymphoma: A retrospective study by the EBMT Lymphoma Working Party.Biol Blood Marrow Transplant.
Paviglianiti, A., Maio, K.Tozatto, Rocha, V., Gehlkopf, E., Milpied, N., Esquirol, A., Chevallier, P., Blaise, D., Gac, A.-C., Leblond, V., et al. (2018). Outcomes of advanced Hodgkin lymphoma after umbilical cord blood transplantation: a Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party study.Biol Blood Marrow Transplant.
Guillaume, T., Dehame, V., Chevallier, P., Peterlin, P., Garnier, A., Gregoire, M., Pichinuk, E., Rubinstein, D.B., and Wreschner, D.H. (2018). Targeting cell-bound MUC1 on myelomonocytic, monocytic leukemias and phenotypically defined leukemic stem cells with anti-SEA module antibodies.Exp Hematol.